Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Niu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560. The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows. Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, S...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-09-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoh-peer-reviewed-fulltext-article-DMSO |
_version_ | 1797682530511486976 |
---|---|
author | Niu S Ren Q Chen S Pan X Yue L Chen X Li Z Zhen R |
author_facet | Niu S Ren Q Chen S Pan X Yue L Chen X Li Z Zhen R |
author_sort | Niu S |
collection | DOAJ |
description | Niu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560.
The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows.
Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China, Email chenshuc2014@163.com
The authors apologize for this error. |
first_indexed | 2024-03-12T00:02:11Z |
format | Article |
id | doaj.art-70c2babf72a34532ba0f7531bbe1e1a0 |
institution | Directory Open Access Journal |
issn | 1178-7007 |
language | English |
last_indexed | 2024-03-12T00:02:11Z |
publishDate | 2023-09-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Diabetes, Metabolic Syndrome and Obesity |
spelling | doaj.art-70c2babf72a34532ba0f7531bbe1e1a02023-09-17T16:39:52ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072023-09-01Volume 162833283486737Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]Niu SRen QChen SPan XYue LChen XLi ZZhen RNiu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560. The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows. Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China, Email chenshuc2014@163.com The authors apologize for this error.https://www.dovepress.com/corrigendum-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoh-peer-reviewed-fulltext-article-DMSOnafldempagliflozinmetabolomicsdifferentially expressed metabolitesobesity |
spellingShingle | Niu S Ren Q Chen S Pan X Yue L Chen X Li Z Zhen R Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum] Diabetes, Metabolic Syndrome and Obesity nafld empagliflozin metabolomics differentially expressed metabolites obesity |
title | Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum] |
title_full | Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum] |
title_fullStr | Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum] |
title_full_unstemmed | Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum] |
title_short | Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum] |
title_sort | metabolic and hepatic effects of empagliflozin on nonalcoholic fatty liver mice corrigendum |
topic | nafld empagliflozin metabolomics differentially expressed metabolites obesity |
url | https://www.dovepress.com/corrigendum-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoh-peer-reviewed-fulltext-article-DMSO |
work_keys_str_mv | AT nius metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum AT renq metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum AT chens metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum AT panx metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum AT yuel metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum AT chenx metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum AT liz metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum AT zhenr metabolicandhepaticeffectsofempagliflozinonnonalcoholicfattylivermicecorrigendum |